|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of debt financing costs | |||||
| Real estate inventory valuation adjustment | |||||
| Stock-based compensation | |||||
| Change in fair value of warrant liabilities | |||||
| Loss on disposal of property and equipment | |||||
| Gain on sale of derivative instruments | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Real estate inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Purchases of derivative instruments | |||||
| Proceeds from sale of derivative instruments | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings from secured credit facilities and other debt | |||||
| Repayments of secured credit facilities and other debt | |||||
| Payment of debt financing costs | |||||
| Borrowings on revolving credit facility | |||||
| Proceeds from July 2025 Offering | |||||
| Issuance costs of July 2025 Offering | |||||
| Proceeds from Sale Agreement offering | |||||
| Issuance costs of Sale Agreement offering | |||||
| Proceeds from exercise of stock options | |||||
| Payments for taxes related to stock-based awards | |||||
| Borrowings from warehouse lending facility | |||||
| Repayments of warehouse lending facility | |||||
| Proceeds from issuance of pre-funded warrants | |||||
| Proceeds from exercise of pre-funded warrants | |||||
| Issuance cost of pre-funded warrants | |||||
| Net cash used in financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Total cash, cash equivalents and restricted cash | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash payments for interest | |||||
| Cash payments for taxes, net of refunds received | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Transfer of property and equipment, net to real estate inventory | |||||
| Acquisition of warrant liabilities | |||||
| Conversion of preferred stock to common stock | |||||
| Treasury Stocks (Member) | |||||
| Total conversion of preferred stock to common stock | |||||
| Transfer of real estate inventory to property and equipment, net | |||||
Loading...